A detailed history of Degroof Petercam Asset Management transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Degroof Petercam Asset Management holds 2,520 shares of ALNY stock, worth $695,998. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,520
Previous 2,520 -0.0%
Holding current value
$695,998
Previous $482 Million 21.92%
% of portfolio
0.0%
Previous 0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$151.41 - $196.57 $381,553 - $495,356
2,520 New
2,520 $482 Million

Others Institutions Holding ALNY

About ALNYLAM PHARMACEUTICALS, INC.


  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $34B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Degroof Petercam Asset Management Portfolio

Follow Degroof Petercam Asset Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Degroof Petercam Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Degroof Petercam Asset Management with notifications on news.